Results 21 to 30 of about 45,096 (205)

Towards a Pharmacophore for Amyloid [PDF]

open access: yesPLoS Biology, 2011
Diagnosing and treating Alzheimer's and other diseases associated with amyloid fibers remains a great challenge despite intensive research. To aid in this effort, we present atomic structures of fiber-forming segments of proteins involved in Alzheimer's disease in complex with small molecule binders, determined by X-ray microcrystallography.
Landau, Meytal   +8 more
openaire   +5 more sources

KNIME pharmacophore nodes

open access: yes, 2023
<p><a href="https://www.knime.com">KNIME</a> plugin with nodes to convert and align pharmacophores.</p> <p>A pharmacophore is an abstract description of molecular features that are necessary for molecular recognition of a ...
Stefan Verhoeven
core   +1 more source

Docking analysis for identification of lead compound and 3d pharmacophore generation against gsk-3β involved in bipolar disorder

open access: yesPakistan Journal of Pharmaceutical Sciences, 2020
Bipolar disorder is a psychiatric illness that strikes between mania and depression, caused by both genetic and environmental factors. It is the sixth leading cause of disability worldwide and 3% of the global population suffers from this disorder ...
Ayesha Sahar   +3 more
doaj   +1 more source

Applications of the Novel Quantitative Pharmacophore Activity Relationship Method QPhAR in Virtual Screening and Lead-Optimisation

open access: yesPharmaceuticals, 2022
Pharmacophores are an established concept for the modelling of ligand–receptor interactions based on the abstract representations of stereoelectronic molecular features.
Stefan Michael Kohlbacher   +3 more
doaj   +1 more source

DrugOn: a fully integrated pharmacophore modeling and structure optimization toolkit [PDF]

open access: yesPeerJ, 2015
During the past few years, pharmacophore modeling has become one of the key components in computer-aided drug design and in modern drug discovery.
Dimitrios Vlachakis   +4 more
doaj   +2 more sources

Pharmacophore-based virtual screening, molecular docking, and molecular dynamics studies for the discovery of novel FLT3 inhibitors

open access: yes, 2022
FLT3 is considered a potential target of acute myeloid leukemia therapy. In this study, we applied a computer-aided methodology unifying molecular docking and pharmacophore screening to identify potent inhibitors against FLT3.
Souad Elkhattabi (13802147)   +5 more
core   +1 more source

Design of dual ligands using excessive pharmacophore query alignment : from 7th German Conference on Chemoinformatics: 25 CIC-Workshop Goslar, Germany, 6 - 8 November 2011 [PDF]

open access: yes, 2012
Dual- or multi-target ligands have gained increased attention in the past years due to several advantages, including more simple pharmacokinetic and phamarcodynamic properties compared to a combined application of several drugs.
Achenbach Janosch   +26 more
core   +1 more source

Pharmacophore-guided drug design using LdNMT as a model drug target for leishmaniasis

open access: yes, 2023
Leishmaniasis is caused by Leishmania genus parasites and has a high mortality rate. The available drugs to treat leishmaniasis fail due to acquired resistance in parasites.
Sonavane Uddavesh (15351654)   +3 more
core   +1 more source

Elucidation of the Teixobactin Pharmacophore [PDF]

open access: yesACS Chemical Biology, 2016
This paper elucidates the teixobactin pharmacophore by comparing the arginine analogue of teixobactin Arg10-teixobactin to seven homologues with varying structure and stereochemistry. The roles of the guanidinium group at position 10, the stereochemistry of the macrolactone ring, and the "tail" comprising residues 1-5 are investigated.
Yang, Hyunjun   +2 more
openaire   +4 more sources

Pharmacophore mapping: Prediction of BCR–ABL kinase inhibitory activity of α-benzylthio chalcones

open access: yesBulletin of Faculty of Pharmacy Cairo University, 2014
In this investigation, 3D pharmacophore modeling studies were performed on a diverse set of 33 α-benzylthio chalcone derivatives that demonstrate anticancer activity by blocking BCR–ABL phosphorylation in leukemic cells.
Richa Bajaj, Vikas Sharma, Vipin Kumar
doaj   +1 more source

Home - About - Disclaimer - Privacy